1-(Hetero)Aryl-3-Amino-Pyrrolidine Derivatives for Use as Mglur3 Antagonists
申请人:Britton Thomas Charles
公开号:US20080300266A1
公开(公告)日:2008-12-04
The present invention relates to compounds of the Formula (I) which are useful for treating conditions associated with mGluR3 receptors, such as depression, schizophrenia and migraine, pharmaceutical compositions thereof, and methods of using the same.
1-(HETERO)ARYL-3-AMINO-PYRROLIDINE DERIVATIVES FOR USE AS MGLUR3 RECEPTOR ANTAGONISTS
申请人:ELI LILLY AND COMPANY
公开号:EP1805165B1
公开(公告)日:2009-12-16
1-(HETERO)ARYL-3-AMINO-PYROLLIDINE DERIVATIVES FOR USE AS MGLUR3 RECEPTOR ANTAGONISTS
申请人:ELI LILLY AND COMPANY
公开号:EP1805165A1
公开(公告)日:2007-07-11
US7868014B2
申请人:——
公开号:US7868014B2
公开(公告)日:2011-01-11
[EN] 1-(HETERO)ARYL-3-AMINO-PYROLLIDINE DERIVATIVES FOR USE AS MGLUR3 RECEPTOR ANTAGONISTS<br/>[FR] DERIVES DE 1-(HETERO)ARYL-3-AMINO-PYROLLIDINE UTILES COMME ANTAGONISTES DES RECEPTEURS MGLUR3
申请人:LILLY CO ELI
公开号:WO2006044454A1
公开(公告)日:2006-04-27
[EN] The present invention relates to compounds of the Formula (I) which are useful for treating conditions associated with mGluR3 receptors, such as depression, schizophrenia and migraine, pharmaceutical compositions thereof, and methods of using the same. [FR] L'invention concerne des composés représentés par la formule (I), utiles dans le traitement d'affections associées aux récepteurs mGluR3, telles que la dépression, la schizophrénie et la migraine, des compositions pharmaceutiques contenant ces composés et des procédés d'utilisation de ceux-ci.